Astra’s CEO to head pharma trade group
AstraZeneca PLC's chief executive officer, David Brennan, was elected board chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.
AstraZeneca PLC's chief executive officer, David Brennan, was elected board chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.
Brennan succeeds Merck & Co. Inc. CEO Richard T. Clark.
PhRMA represents the country's largest pharmaceutical research and biotechnology companies.
AstraZeneca is based in London but has U.S. headquarters in Wilmington. - Miriam Hill
Review
Andrew Ackerman, Bloomberg
Rebecca Robbins, New York Times
Julia Carpenter, Washington Post
Christopher Rugaber, Associated Press
Gene Marks, For The Inquirer
Tracey Tully and Peter Eavis, New York Times
Kim Bhasin, New York Times
Kevin Brasler, Delaware Valley Consumers' Checkbook
Alicia Adamczyk, Washington Post
Todd Wallack, Washington Post
Jesse Bedayn and Barbara Ortutay, Associated Press
Associated Press
























